Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Posted on 25/03/202525/03/2025 by Pencis

Dr. Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Dr. Xiaodi Tang, Beijing Tsinghua Changgung Hospital, Tsinghua University, China

Dr. Xiaodi Tang is a Ph.D. candidate in Clinical Medicine at Tsinghua University, Beijing Tsinghua Changgung Hospital, specializing in heart rate variability (HRV) in heart failure. A licensed practicing physician in China, Dr. Tang completed residency training in cardiovascular medicine and holds a Master of Medicine from Harbin Medical University, focusing on SGLT2 inhibitors in HFpEF and diabetes. With expertise in advanced statistical analysis (R) and longitudinal cohort study design, Dr. Tang’s research aims to enhance cardiac risk assessment and personalized treatment strategies, contributing to precision medicine and innovative diagnostics in cardiovascular healthcare.

AUTHOR PROFILE

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Xiaodi Tang embarked on an academic journey rooted in medical excellence. Pursuing a Master of Medicine in Cardiovascular Internal Medicine at Harbin Medical University, Dr. Tang dedicated early research to the cardiovascular protection of sodium-glucose cotransporter 2 (SGLT2) inhibitors in heart failure with preserved ejection fraction (HFpEF) and diabetes. This work laid the foundation for a deeper exploration into cardiovascular medicine, integrating clinical experience with scientific inquiry.

🏥PROFESSIONAL ENDEAVORS:

As a Licensed Practicing Physician in China, Dr. Tang has completed rigorous residency training in cardiovascular medicine, gaining hands-on experience in diagnosing and treating complex cardiac conditions. This clinical expertise has been instrumental in bridging the gap between research and patient care, ensuring that scientific advancements translate into improved treatment protocols.

🔍CONTRIBUTIONS AND RESEARCH FOCUS CARDIOVASCULAR MEDICINE:

Dr. Tang is currently a Ph.D. Candidate in Clinical Medicine at Tsinghua University, Beijing Tsinghua Changgung Hospital, with a research concentration on heart rate variability (HRV) in heart failure. By utilizing advanced statistical analysis (R) and longitudinal cohort study design, Dr. Tang’s research seeks to uncover new insights into cardiac autonomic regulation and its role in heart failure prognosis.

💉KEY RESEARCH CONTRIBUTIONS:

Heart Rate Variability (HRV) in Heart Failure – Investigating the predictive value of HRV for cardiovascular outcomes.
SGLT2 Inhibitors and Cardiovascular Protection – Exploring their therapeutic potential in HFpEF and diabetic patients.
Longitudinal Cohort Studies – Applying advanced methodologies to track cardiovascular health over time.

🌍IMPACT AND INFLUENCE:

Dr. Tang’s work holds significant implications for clinical cardiology, particularly in developing non-invasive biomarkers for heart failure prognosis. By integrating statistical modeling with clinical insights, this research has the potential to refine risk stratification and personalize treatment strategies for patients with cardiac disorders.

📚ACADEMIC CITES & RECOGNITION:

Dr. Tang’s contributions are gaining recognition in peer-reviewed journals and conferences, with citations expected to grow as research findings are published and disseminated within the global cardiology community. The emphasis on HRV as a diagnostic tool aligns with contemporary efforts to enhance precision medicine in cardiovascular care.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

With a strong foundation in cardiovascular medicine and clinical research, Dr. Tang is poised to make lasting contributions to the field. The future trajectory includes:
Furthering HRV-based diagnostics for cardiac conditions.
Developing innovative therapeutic approaches for heart failure patients.
Mentoring future researchers in cardiovascular studies.
Expanding clinical applications of AI-driven predictive analytics in cardiology.

Dr. Xiaodi Tang’s journey exemplifies a commitment to scientific advancement, clinical excellence, and transformative research in cardiovascular medicine. The integration of cutting-edge analytics, patient-centered studies, and innovative therapeutic exploration positions Dr. Tang as a rising leader in the global cardiology landscape.

💡CONCLUSION:

Dr. Xiaodi Tang’s dedication to cardiovascular research and clinical excellence is shaping the future of heart failure diagnostics and treatment. With a strong foundation in heart rate variability (HRV), SGLT2 inhibitors, and advanced statistical analysis, Dr. Tang is driving precision medicine forward. By integrating research, clinical expertise, and innovative methodologies, Dr. Tang’s work has the potential to redefine patient care and improve cardiovascular outcomes. As a rising leader in cardiology, Dr. Tang continues to push the boundaries of medical science, paving the way for more effective, personalized, and data-driven healthcare solutions.

TOP NOTABLE PUBLICATIONS:

“Association between ultra-short-term heart rate variability of time fluctuation and atrial fibrillation: evidence from MIMIC-IV”

Authors: Information not available in the provided sources.

Journal: Heart Rhythm O2

Year: 2025

“The association of triglyceride-glucose and triglyceride-glucose related indices with the risk of heart disease in a national”

Authors: Information not available in the provided sources.

Journal: Cardiovascular Diabetology

Year: 2025

Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Posted on 25/02/202525/02/2025 by Pencis

Prof. Dr. Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Prof. Dr. Zhuofeng Lin, Guangdong Medical University, China

Prof. Dr. Zhuofeng Lin is the Dean of the Experimental Animal Center and Dean of the Innovational Center of Cardiometabolic Disease at Guangdong Medical University, China. His research focuses on cross-organ communication in cardiovascular and metabolic diseases, particularly the role of metabolic hormones and obesity. He has made significant contributions to understanding FGF21 metabolic regulation, impacting blood glucose stability, blood pressure control, and anti-atherosclerosis therapies. His work also explores new targets for anti-myocardial infarction, heart failure, and vascular calcification drugs, driving innovation in metabolic and cardiovascular medicine. His research is widely recognized in international medical science.

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Zhuofeng Lin’s academic journey began with a strong foundation in medical sciences, focusing on cardiovascular and metabolic diseases. His early research explored physiological mechanisms and metabolic interactions, leading him to specialize in cross-organ communication and metabolic regulation. His education and initial training laid the groundwork for his extensive contributions to cardiometabolic research.

🏢PROFESSIONAL ENDEAVORS:

Prof. Lin has held prestigious positions at Guangdong Medical University, where he currently serves as:

Dean of the Experimental Animal Center 🐁
Dean of the Innovational Center of Cardiometabolic Disease 🫀

His leadership in these institutions has driven significant advancements in experimental research methodologies and the development of innovative treatment strategies for metabolic disorders.

🔍CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Prof. Lin’s research is dedicated to practical applications, with a strong emphasis on:

Cross-organ communication in cardiovascular and metabolic diseases
Pathogenesis of cardiometabolic disorders linked to metabolic hormones and obesity
Fibroblast Growth Factor 21 (FGF21) and its role in metabolic regulation

His studies have provided groundbreaking insights into FGF21’s ability to regulate:
✅ Blood glucose levels
✅ Blood pressure stability
✅ Anti-atherosclerosis mechanisms
✅ Anti-Metabolic Dysfunction-Associated Steatohepatitis (MASH) therapies

Additionally, his work focuses on discovering new therapeutic targets for:
⚕️ Anti-myocardial infarction drugs
⚕️ Anti-heart failure treatments
⚕️ Anti-vascular calcification solutions

🌍IMPACT AND INFLUENCE:

Prof. Lin’s research has had a profound impact on global medical science, particularly in the fields of:
🔹 Metabolic disease management
🔹 Cardiovascular treatment innovations
🔹 Therapeutic drug development

His studies have influenced clinical practices, contributing to better patient outcomes in cardiovascular and metabolic health. His pioneering work in hormonal regulation and metabolic stability has inspired numerous scientists and researchers worldwide.

📄ACADEMIC CITES AND RECOGNITION:

Prof. Lin’s research is widely recognized in high-impact medical journals, with numerous citations supporting his theories. His work on FGF21 metabolic regulation is frequently referenced in the fields of endocrinology, cardiology, and metabolic research. He has been a keynote speaker at international medical conferences, sharing his insights with the global scientific community.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

With an unwavering commitment to scientific innovation, Prof. Lin continues to shape the future of medical research. His ongoing projects aim to:
🔬 Develop novel cardiometabolic therapies
🔬 Enhance cross-organ communication research
🔬 Introduce cutting-edge treatments for heart disease and metabolic disorders

His legacy will be defined by his transformative contributions to medicine, paving the way for future breakthroughs in cardiovascular and metabolic health.

💡CONCLUSION:

Prof. Dr. Zhuofeng Lin is a pioneering leader in cardiometabolic research, making groundbreaking contributions to understanding metabolic regulation and cardiovascular health. His work on FGF21 has revolutionized approaches to blood glucose stability, blood pressure control, and anti-atherosclerosis treatments . With a vision for therapeutic innovation, he continues to explore new drug targets for heart failure, myocardial infarction, and vascular calcification . His impact on medical science is profound, shaping the future of metabolic and cardiovascular treatments. His dedication ensures lasting advancements in healthcare and patient well-being.

TOP NOTABLE PUBLICATIONS

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Authors: Z Lin, H Tian, KSL Lam, S Lin, RCL Hoo, M Konishi, N Itoh, Y Wang, …
Journal: Cell Metabolism
Year: 2013

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice

Authors: Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L Jin, Q Lian, Y Huang, …
Journal: Circulation
Year: 2015

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

Authors: Z Lin, Z Wu, X Yin, Y Liu, X Yan, S Lin, J Xiao, X Wang, W Feng, X Li
Journal: PLoS One
Year: 2010

Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues

Authors: L Geng, B Liao, L Jin, Z Huang, CR Triggle, H Ding, J Zhang, Y Huang, …
Journal: Cell Reports
Year: 2019

Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2

Authors: D Ye, K Yang, S Zang, Z Lin, HT Chau, Y Wang, J Zhang, J Shi, A Xu, …
Journal: Journal of Hepatology
Year: 2016

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

Authors: Z Lin, Z Zhou, Y Liu, Q Gong, X Yan, J Xiao, X Wang, S Lin, W Feng, X Li
Journal: PLoS One
Year: 2011

FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1–7) axis in mice

Authors: X Pan, Y Shao, F Wu, Y Wang, R Xiong, J Zheng, H Tian, B Wang, …
Journal: Cell Metabolism
Year: 2018

Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice

Authors: Z Lin, F Wu, S Lin, X Pan, L Jin, T Lu, L Shi, Y Wang, A Xu, X Li
Journal: Journal of Hepatology
Year: 2014

Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling‐dependent manner

Authors: Y Pan, B Wang, J Zheng, R Xiong, Z Fan, Y Ye, S Zhang, Q Li, F Gong, …
Journal: Journal of Cellular and Molecular Medicine
Year: 2019

Dynamic change of serum FGF21 levels in response to glucose challenge in human

Authors: Z Lin, Q Gong, C Wu, J Yu, T Lu, X Pan, S Lin, X Li
Journal: The Journal of Clinical Endocrinology & Metabolism
Year: 2012

Pin-fang Kang | Cardiology | Best Researcher Award

Posted on 24/02/202524/02/2025 by Pencis

Mrs. Pin-fang Kang | Cardiology | Best Researcher Award

Mrs. Pin-fang Kang, Department of Cardiovascular Medicine of The First Affiliated Hospital of Bengbu Medical University, China

Mrs. Pin-fang Kang is a distinguished cardiovascular medicine specialist at the Department of Cardiovascular Medicine, The First Affiliated Hospital of Bengbu Medical University, China. Her research focuses on pulmonary hypertension, coronary artery disease, and cardiovascular therapies, contributing significantly to cardiology and medical innovation. She has co-authored multiple high-impact publications in prestigious journals, advancing the understanding of heart disease mechanisms and treatments. Her expertise in molecular cardiology and patient care has made her a key figure in cardiovascular research. Through her work, she continues to influence diagnostics, treatment strategies, and the future of cardiovascular medicine.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Mrs. Pin-fang Kang embarked on her academic journey with a strong passion for medical sciences, particularly in cardiovascular medicine. Her foundational education laid a solid groundwork for her future contributions in the field. She pursued rigorous training in medical studies, focusing on internal medicine and cardiovascular health, preparing her for a career dedicated to patient care and clinical research.

👩‍⚕️ PROFESSIONAL ENDEAVORS:

Currently serving in the Department of Cardiovascular Medicine at The First Affiliated Hospital of Bengbu Medical University, China, Mrs. Kang has established herself as a distinguished medical professional. Her expertise spans clinical cardiology, patient management, and innovative treatment approaches. She has actively engaged in treating various cardiovascular diseases, including hypertension, coronary artery disease, and heart failure.

🏥 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY:

Mrs. Kang has significantly contributed to advancing cardiovascular treatment methodologies. Her research primarily focuses on:

Innovative cardiovascular interventions
Prevention and management of heart diseases
The role of lifestyle and genetics in cardiovascular health
The impact of modern therapies on patient outcomes

Through her dedication to research and evidence-based medical practice, she has played a crucial role in improving cardiovascular health policies and patient treatment protocols.

🌍 IMPACT AND INFLUENCE:

Her work has influenced the Chinese medical community and contributed to global advancements in cardiovascular medicine. By integrating cutting-edge research with clinical applications, she has enhanced patient care and treatment methodologies. Her role as a mentor and educator at Bengbu Medical University has also inspired many young medical professionals.

📑 ACADEMIC CITES:

Mrs. Kang’s research has been cited in various scientific journals and medical conferences, establishing her as a key contributor to the field of cardiology. Her work has been referenced in:

Cardiovascular medical journals
International cardiology symposiums
Collaborative research studies with other medical institutions

🔬 LEGACY AND FUTURE CONTRIBUTIONS:

Mrs. Pin-fang Kang continues to pave the way for new advancements in cardiovascular medicine. Her future contributions are expected to revolutionize treatment strategies, enhance patient care, and mentor the next generation of cardiologists. With a commitment to medical excellence and innovation, she remains a pillar of the cardiovascular medical community.

⭐CONCLUSION:

Mrs. Pin-fang Kang stands as a dedicated expert in cardiovascular medicine, making remarkable contributions to research, patient care, and medical innovation. Her work on pulmonary hypertension, coronary artery disease, and advanced treatment methods has significantly impacted the field of cardiology. Through her cutting-edge research and clinical expertise, she continues to shape the future of cardiovascular health. As a respected figure in medical science, her dedication to improving diagnostics and therapies inspires the next generation of researchers and clinicians. Her legacy in cardiology remains invaluable for global healthcare advancements.

TOP NOTABLE PUBLICATIONS

Salidroside Ameliorates Hypoxic Pulmonary Hypertension by Regulating the Two-Pore Domain Potassium TASK-1 Channel

Authors: Zheng-Yu Sun, Guo-Qing Lu, Hong-Yan Sun, Wen-Di Jiang, Lei Wang, Yu-Hang Wang, Le-Qiang Liu, Hong-Ju Wang, Bi Tang, Qin Gao, Pin-Fang Kang

Journal: Phytomedicine

Year: 2024

Exploring the Diagnostic and Immune Infiltration Roles of Disulfidptosis Related Genes in Pulmonary Hypertension

Authors: Xin Tan, Ningning Zhang, Ge Zhang, Shuai Xu, Yiyao Zeng, Fenlan Bian, Bi Tang, Hongju Wang, Jili Fan, Xiaohong Bo, Yangjun Fu, Huimin Fan, Yafeng Zhou, Pinfang Kang

Journal: Respiratory Research

Year: 2024

Predicting Angiographic Coronary Artery Disease Using Machine Learning and High-Frequency QRS

Authors: Jiajia Zhang, Heng Zhang, Ting Wei, Bi Tang, Hongju Wang

Journal: BMC Medical Informatics and Decision Making

Year: 2024

Effect of NLRP3 Gene Knockdown on Pyroptosis and Ferroptosis in Diabetic Cardiomyopathy Injury

Authors: Jiahui Wang, Yuping Li, Lu Li, Ying Yu, Qin Gao

Journal: BMC Cardiovascular Disorders

Year: 2024

Activation of ALDH2 Alleviates Hypoxic Pulmonary Hypertension in Mice by Upregulating the SIRT1/PGC-1α Signaling Pathway

Authors: Lei Wang, Fenlan Bian, Feiyang Ma, Pin-Fang Kang, Shili Wu

Journal: Journal of Southern Medical University

Year: 2024

Quercetin Ameliorates Diabetic Kidney Injury in Rats by Inhibiting the HMGB1/RAGE/NF-κB Signaling Pathway

Authors: Y. Jiang, X. Li, J. Geng, Bi Tang, Pin-Fang Kang

Journal: Journal of Southern Medical University

Year: 2024

Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Prof. Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Prof. Litao Guo, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Prof. Litao Guo is a Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China. With over 18 years of experience in intensive care medicine, he specializes in cardiopulmonary resuscitation (CPR), ECMO therapy, and critical patient management. Prof. Guo is also an expert in intelligent simulation teaching for emergency skills training. His research includes advanced ECMO treatments and innovative CPR training methods using intelligent simulation platforms. He has published 16 research papers, contributing significantly to critical care medicine and improving patient outcomes in high-risk medical situations.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Litao Guo embarked on his academic journey in intensive care medicine, where he spent more than 18 years developing his expertise. From a resident to an associate chief physician, he gained valuable experience and hands-on knowledge in managing critically ill patients. Prof. Guo has also served as a master tutor, fostering the next generation of healthcare professionals, particularly in cardiopulmonary resuscitation (CPR) and ECMO treatment. This foundation in intensive care provided him with a deep understanding of patient management and critical interventions.

💼PROFESSIONAL ENDEAVORS:

Currently, Prof. Guo serves as the Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University in Xi’an, China. His daily responsibilities include overseeing the treatment and management of critically ill patients, particularly those requiring advanced life-saving procedures such as ECMO and CPR. He plays a pivotal role in shaping clinical practices, guiding patient care, and contributing to the advancement of intensive care medicine. His leadership is integral to the hospital’s focus on improving patient outcomes in high-stakes medical situations.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Prof. Guo is widely recognized for his research on intelligent simulation teaching and training methods, particularly in CPR. His work involves leveraging cutting-edge technology to enhance the teaching and practical skills of medical staff in emergency procedures. He has been instrumental in developing an intelligent simulation platform to train teams in effective CPR techniques, emphasizing team coordination, division of labor, and the standing position during resuscitation efforts. Additionally, his research delves into the management of ECMO therapy, focusing on treating complications such as massive airway bleeding with early clamping and advanced intervention measures.

🌍IMPACT AND INFLUENCE:

Prof. Guo’s research and clinical contributions have had a significant impact on improving outcomes for critically ill patients. His work on ECMO combined with advanced airway management has been especially groundbreaking, offering new insights and techniques to reduce mortality rates. His intelligent simulation teaching platform is transforming the way first responders and healthcare professionals are trained, ensuring they are equipped with the best skills to save lives. Prof. Guo’s publications, including 16 relevant research papers, have gained widespread recognition within the medical community.

📚ACADEMIC CITATIONS:

Prof. Guo has published 16 research papers, many of which focus on innovative approaches to CPR and ECMO. His scholarly work has contributed to the growing body of knowledge in intensive care medicine, particularly in areas that directly affect patient survival in critical care settings. These publications are frequently cited by other researchers, underscoring the importance of his work in advancing medical practice.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Guo is dedicated to further advancing intensive care medicine through both his clinical practice and research endeavors. His focus on innovative training techniques and treatment protocols, such as ECMO and CPR management, ensures that future healthcare providers will be well-equipped to manage complex and life-threatening situations. His legacy will be one of continuous improvement in the fields of sepsis, resuscitation, and critical care, with lasting effects on the healthcare system and patient care outcomes.

🌟CONCLUSION:

Prof. Litao Guo’s work in intensive care medicine, particularly in cardiopulmonary resuscitation (CPR) and ECMO therapy, has had a profound impact on improving patient care and outcomes in critical settings. His pioneering research on intelligent simulation platforms for emergency training is revolutionizing medical education, ensuring better preparedness among healthcare teams. With over 18 years of experience and 16 published papers, his contributions continue to shape the field. Prof. Guo’s commitment to advancing both clinical practice and medical education ensures that his legacy will inspire future generations of healthcare professionals.

TOP NOTABLE PUBLICATIONS

Exploration of cardiopulmonary resuscitation teamwork training for maternal cardiac arrest using the SimMan intelligent simulation platform: A simulation teaching study

Authors: Zhang, Ruirui; Liu, Yu; Zhang, Mingming; Bai, Hongliang; Guo, Litao

Journal: Health Science Reports

Year: 2024

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Authors: Vaara, Suvi T.; Neto, Ary Serpa; Bellomo, Rinaldo; Yang, Yang; Padayachee, Laven

Journal: Critical Care Explorations

Year: 2024

Eliza Wong | Cardiac Nursing | Best Researcher Award

Posted on 22/01/202524/01/2025 by Pencis

Dr. Eliza Wong | Cardiac Nursing | Best Researcher Award

Dr. Eliza Wong, Tung Wah College, Hong Kong

Dr. Eliza Wong is an esteemed Associate Professor at Tung Wah College, Hong Kong, with extensive experience in nursing education, research, and clinical practice. She specializes in e-health interventions, acute care, and cardiovascular nursing, focusing on preventive care, gerontechnology, and lifestyle educational programs. Dr. Wong’s impactful research has garnered substantial funding, including Health and Medical Research Fund (HMRF) grants, and her work is widely published in leading international journals. A dedicated mentor and global collaborator, she actively advances nursing education and practice, shaping the next generation of healthcare professionals and contributing to improved patient outcomes worldwide.

Author Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

EDUCATION:

Dr. Wong Mi Ling, Eliza, possesses an impressive academic foundation in nursing and healthcare management. She earned her PhD in Nursing from The Chinese University of Hong Kong (2003–2009), focusing on improving patient care through evidence-based research. She also holds a Master of Nursing from Deakin University, Australia (1999–2001), and a Master of Health Administration from the University of New South Wales, Australia (1995–1997), which reflect her dual expertise in clinical practice and healthcare leadership. Additionally, she completed her Bachelor of Health Science in Nursing at the University of Western Sydney, Australia (1992–1993), establishing her strong clinical foundation.

PROFESSIONAL QUALIFICATION:

Dr. Wong Mi Ling, Eliza, boasts outstanding professional qualifications in nursing and healthcare. She is a Fellow of the Hong Kong College of Education and Research at the Hong Kong Academy of Nursing (HKAN) since 2012 . A committed member of Sigma (Pi Lota at-Large Chapter) , she has been a Registered General Nurse in Hong Kong since 1982 and a Registered Midwife since 1984 . Her international credentials include being a Registered Nurse in NSW, Australia (1990–2017). Additionally, she has certifications in International Trauma Life Support (2017–2021) and Basic Life Support (2017–2019) .

PROFESSIONAL EXPERIENCE:

Dr. Wong Mi Ling, Eliza, has an extensive professional journey in nursing and education. She serves as an Associate Professor at Tung Wah College (2021–present) and previously held roles at the Polytechnic University of Hong Kong as Principal Research Fellow (2020–2021) and Assistant Professor (2017–2020) . She has also contributed as a Nurse Educator at Hong Kong Sanatorium & Hospital (2016–2017) and Assistant Professor at CUHK (2010–2016) . Her diverse experience spans roles in nursing education, consultancy, and frontline care in Hong Kong and Australia, including A&E, obstetrics, and rehabilitation units .

RESEARCH INTERESTS ON CARDIAC NURSING:

Dr. Wong Mi Ling, Eliza, research interests encompass e-health interventions for conditions like coronary heart disease and metabolic syndrome, acute care with a focus on pain and emergency nursing, and cardiovascular nursing, including preventive care, rehabilitation, and lifestyle education. Their PhD research emphasized educational interventions in acute pain management for patients with limb fractures. With extensive experience in emergency nursing, their studies explore nurse-led wound care and triage pain management. Since 2017, they have focused on gerontechnology and health literacy for older adults, securing significant grants. Their prolific contributions include 46 international publications, numerous impactful conference papers, and active roles in collaborative research and peer review.

AWARDS AND HONORS:

Dr. Wong Mi Ling, Eliza has received numerous awards and honors throughout her distinguished career. Her accolades reflect her outstanding contributions to nursing education, research, and practice. Dr. Wong has been recognized for her impactful work in cardiovascular nursing and e-health interventions, securing prestigious research grants such as the Health and Medical Research Fund (HMRF) and Knowledge Transfer Fund. She serves as a member of the International Advisory Board for International Emergency Nursing and actively contributes as a peer reviewer for esteemed journals like BMJ Open Access and the Journal of Advanced Nursing. Her dedication continues to inspire excellence in nursing.

CITATIONS:

Citations – 2074
h-index – 26
i10-index – 58

CONCLUSION:

Dr. Wong Mi Ling, Eliza has established herself as a visionary leader in nursing, blending rich clinical experience with groundbreaking research and education. Her contributions to e-health interventions, acute care, and cardiovascular nursing have significantly advanced nursing practice and patient care. Through her commitment to mentorship, she has nurtured the next generation of healthcare professionals, fostering innovation and academic excellence. With a global reputation as a scholar, advisor, and educator, Dr. Wong continues to drive progress in nursing, ensuring her work has a lasting impact on healthcare systems and communities worldwide. Her dedication remains a beacon of inspiration and excellence.

TOP NOTABLE PUBLICATIONS

Title: The associations of e-health perception and dementia knowledge with dementia public stigma in nursing students: A cross-sectional study
Authors: Su, J.J., Tsui, K.Y., Lam, S.C., Suen, L.K.P., Kwan, R.Y.C.
Journal: Nurse Education Today
Year: 2025, 146, 106532

Title: Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled Trial
Authors: Wong, E.M.L., Leung, D.Y.P., Lam, S.C., Ko, S.Y., Leung, A.Y.M.
Journal: Worldviews on Evidence-Based Nursing
Year: 2025, 22(1), e12765

Title: Lifestyle intervention using a mobile application versus booklet for adults with metabolic syndrome: a multicentre randomised controlled trial (abridged secondary publication)
Authors: Leung, D.Y.P., Wong, E.M.L., Leung, A.M.Y., Cheung, A.S.P., Cheung, K.C.
Journal: Hong Kong Medical Journal
Year: 2024, 30(6), pp. 12–16

Title: Coping strategies of internally displaced persons and the host community in a region of armed conflict: A cross-sectional study
Authors: Salihu, D., Chutiyami, M., Bello, U.M., Sulaiman, S.K., Kwan, R.Y.C.
Journal: Psychiatry Research
Year: 2024, 339, 116035

Title: Effectiveness of a home-based music-paced physical activity programme on exercise-related outcomes after cardiac rehabilitation: a randomized controlled trial
Authors: Chair, S.Y., Cheng, H.Y., Lo, S.W.S., Choi, K.C., Leung, T.S.Y.
Journal: European Journal of Cardiovascular Nursing
Year: 2024, 23(5), pp. 510–520

Title: Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Authors: Lo, F., Wong, E., Lam, K., Huang, X., Ho, K.
Journal: Journal of Advanced Nursing
Year: 2024

Title: Effects of virtual reality on anxiety and pain in adult patients undergoing wound-closure procedures: A pilot randomized controlled trial
Authors: Ko, S.Y., Wong, E.M.L., Ngan, T.L., Tam, H.F., Chan, C.C.
Journal: Digital Health
Year: 2024, 10

Title: Music-paced physical activity intervention for patients with coronary heart disease: abridged secondary publication
Authors: Chair, S.Y., Sit, J.W.H., Wong, E.M.L., Yu, D.S.F., Leung, T.S.Y.
Journal: Hong Kong Medical Journal
Year: 2024, 30(1), pp. 18–22

Title: Sensitivity and specificity of conventional and new face validation in determining the incomprehensible items by older people: Empirical evidence of testing 106 quality-of-life items
Authors: Lam, S.C., Suen, L.K.P., Huang, E.Y.-Z., Cheung, D.S.K., Kwan, R.Y.C.
Journal: Aging Medicine
Year: 2023, 6(3), pp. 230–238

Title: The effect of a lifestyle intervention program using a mobile application versus the effect of a program using a booklet for adults with metabolic syndrome: A three-arm randomized controlled trial
Authors: Wong, E.M.L., Leung, D.Y.P., Wang, Q., Leung, A.Y.M., Cheung, A.S.P.
Journal: Journal of Nursing Scholarship
Year: 2023, 55(5), pp. 936–948